Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 18201 - 18225 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Copper	Approved Investigational	EMP2	2013	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of EMP2 mRNA	16p13.13	A21749
Copper	Approved Investigational	EN1	2019	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of EN1 mRNA	2q14.2	A21749
Copper	Approved Investigational	ENC1	8507	upregulated	[Copper results in increased activity of TP53 protein] which results in increased expression of ENC1 mRNA	5q13.3	A21759
Copper	Approved Investigational	ENDOG	2021	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of ENDOG mRNA	9q34.11	A21749
Copper	Approved Investigational	ENPP2	5168	upregulated	[NSC 689534 binds to Copper] which results in increased expression of ENPP2 mRNA	8q24.12	A21749
Copper	Approved Investigational	ENY2	56943	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of ENY2 mRNA	8q23.1	A21749
Copper	Approved Investigational	EPB41L4A-AS1	114915	upregulated	[NSC 689534 binds to Copper] which results in increased expression of EPB41L4A-AS1 mRNA	5q22.1	A21749
Copper	Approved Investigational	EPB41L5	57669	upregulated	[NSC 689534 binds to Copper] which results in increased expression of EPB41L5 mRNA	2q14.2	A21749
Copper	Approved Investigational	EPCAM	4072	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of EPCAM mRNA	2p21	A21749
Copper	Approved Investigational	EPG5	57724	upregulated	[NSC 689534 binds to Copper] which results in increased expression of EPG5 mRNA	18q12.3-q21.1	A21749
Copper	Approved Investigational	ERAP1	51752	upregulated	[NSC 689534 binds to Copper] which results in increased expression of ERAP1 mRNA	5q15	A21749
Copper	Approved Investigational	ERBB3	2065	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of ERBB3 mRNA	12q13.2	A21749
Copper	Approved Investigational	ERP44	23071	upregulated	[NSC 689534 binds to Copper] which results in increased expression of ERP44 mRNA	9q31.1	A21749
Copper	Approved Investigational	ERRFI1	54206	upregulated	[NSC 689534 binds to Copper] which results in increased expression of ERRFI1 mRNA	1p36.23	A21749
Copper	Approved Investigational	ERV3-2	57612	upregulated	[NSC 689534 binds to Copper] which results in increased expression of ERV3-2 mRNA	7q33	A21749
Copper	Approved Investigational	ERVMER34-1	100288413	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of ERVMER34-1 mRNA	4q12	A21749
Copper	Approved Investigational	ESRP1	54845	upregulated	[NSC 689534 binds to Copper] which results in increased expression of ESRP1 mRNA	8q22.1	A21749
Copper	Approved Investigational	ESRP2	80004	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of ESRP2 mRNA	16q22.1	A21749
Copper	Approved Investigational	ETFB	2109	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of ETFB mRNA	19q13.41	A21749
Copper	Approved Investigational	ETS1	2113	upregulated	[Disulfiram binds to Copper] which results in increased expression of ETS1 mRNA	11q24.3	A21750
Copper	Approved Investigational	ETS1	2113	upregulated	[NSC 689534 binds to Copper] which results in increased expression of ETS1 mRNA	11q24.3	A21749
Copper	Approved Investigational	ETV4	2118	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of ETV4 mRNA	17q21.31	A21749
Copper	Approved Investigational	EVA1C	59271	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of EVA1C mRNA	21q22.11	A21749
Copper	Approved Investigational	EXO1	9156	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of EXO1 mRNA	1q43	A21749
Copper	Approved Investigational	EXOC3	11336	upregulated	[NSC 689534 binds to Copper] which results in increased expression of EXOC3 mRNA	5p15.33	A21749

Displaying entries 18201 - 18225 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability